Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease

Part of paid clinical trials in Hackensack, New Jersey.

Sponsor
Herrick Medical LLC
Study ID
NCT05295615
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • ECHS AD Device — DEVICE
    Pulsed electromagnetic therapy device

Study Details

An open label pilot study in mild to moderate AD patients to assess the effects of treatment with ECHS AD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end points are the The Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Mini-Mental State Exam. Participants will be followed-up for 9 months post-treatment.

Key Dates

Start date
May 1, 2023
Status verified
Oct 2024
Primary completion
Dec 30, 2025
Completion
Sep 30, 2026

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Active ECHS AD device
    Experimental intervention arm

Primary Outcome Measure

The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) [ Time Frame: Change between day 0, and 30, 60, 90, 120, 150, 240, 310, 400 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Hackensack Medical CenterHackensackNew Jersey07601-

Find similar trials in Hackensack, NJ

By condition
Alzheimer's disease
By specialty
NeurologyDementia careBrain disordersGeriatrics
By research site
Hackensack Medical Center· Hackensack, NJ

Related Studies